Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: South Korea Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20062
20073
20082
20101
20121
20131
20141
20151
20173
20181
20191
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated3
Unknown status2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi4
Boehringer Ingelheim3
Bristol-Myers Squibb2
Daiichi Sankyo2
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2
Anthos Therapeutics, Inc.1
Bayer1
CSL Behring1
Chong Kun Dang Pharmaceutical1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation22
Stroke5
Arrhythmias, Cardiac2
Atherosclerosis2
Atrial Flutter2
Embolism2
Acute Coronary Syndrome1
Cardiovascular Diseases1
Coronary Artery Disease1
Heart Diseases1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.